Cite
HARVARD Citation
Kawada, M. et al. (2020). Absence of toxic epidermal necrolysis recurrence with pembrolizumab re‐challenge in a patient with a positive lymphocyte transformation test. Journal of dermatology. 47 (12), pp. e424-e425. [Online].